Quick Answer
NeuroSense Therapeutics Ltd. reported Net Income of -$11.12 million for fiscal year 2025.
NeuroSense Therapeutics Ltd. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$11.12M | -9.0% |
| 2024 | -$10.21M | -1.0% |
| 2023 | -$10.11M | +3.7% |
| 2022 | -$10.49M | — |
- NeuroSense Therapeutics Ltd. showed a decrease of -9.0% in Net Income compared to the prior fiscal year.
- Over the 2022–2025 period, NeuroSense Therapeutics Ltd.’s net income has declined by 6.0% (from -$10.49 million to -$11.12 million).
- The most recent figure is from NeuroSense Therapeutics Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: